A detailed history of Simplify Asset Management Inc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 12,497 shares of TGTX stock, worth $438,894. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,497
Previous 10,204 22.47%
Holding current value
$438,894
Previous $367,000 22.89%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$26.39 - $39.19 $60,512 - $89,862
2,293 Added 22.47%
12,497 $451,000
Q2 2025

Aug 07, 2025

SELL
$33.37 - $45.51 $36,173 - $49,332
-1,084 Reduced 9.6%
10,204 $367,000
Q1 2025

May 13, 2025

BUY
$27.67 - $42.99 $1,411 - $2,192
51 Added 0.45%
11,288 $445,000
Q4 2024

Feb 11, 2025

BUY
$21.31 - $35.09 $239,460 - $394,306
11,237 New
11,237 $338,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.1B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.